Showing results (141-150 of 198) with videos related to
Sort By:
Pageof 20
Journal of Personalized Medicine|January 21, 2023
Recognition of Postoperative Cystography Features by Artificial Intelligence to Predict Recovery from Postprostatectomy Urinary Incontinence: A Rapid and Easy Way to Predict Functional OutcomeI-Hung Shao, Hung-Cheng Kan, Hung-Yi Chen, et al.Journal of Advanced Nursing|August 4, 2020
Effectiveness of a couple-based psychosocial intervention on patients with prostate cancer and their partners: A quasi-experimental studyChing-Hui Chien, Hsiao-Jen Chung, Kuan-Lin Liu, et al.Biomaterials|August 30, 2011
Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapyMu-Yi Hua, Hung-Wei Yang, Hao-Li Liu, et al.ACS Nano|January 18, 2012
Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapyHung-Wei Yang, Mu-Yi Hua, Hao-Li Liu, et al.Cancer Genomics & Proteomics|August 19, 2022
Nuclear Respiratory Factor 1 Overexpression Inhibits Proliferation and Migration of PC3 Prostate Cancer CellsChun-Hsien Wu, Pei-Fang Hsieh, Yen-Hsi Lee, et al.Experimental and Therapeutic Medicine|September 29, 2021
Gain of TPPP as a predictor of progression in patients with bladder cancerYing-Hsu Chang, Po-Hung Lin, Chin-Chang Chen, et al.Scientific Reports|August 30, 2024
Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancerI-Hung Shao, Fan-Ting Liao, Chun-Bi Chang, et al.Therapeutics and Clinical Risk Management|December 27, 2024
Predicting Bleeding Related Events in Robotic-Assisted Partial Nephrectomy for Angiomyolipoma: Simplifying Risk Assessment with Tumor Diameter and Depth, A Retrospective StudyMing-Chien Chen, Ying-Hsu Chang, Ting-Wen Sheng, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 20, 2017
Optimal usage of radium-223 in metastatic castration-resistant prostate cancerTai-Lung Cha, Tony Tong-Lin Wu, Nicholas John Vogelzang, et al.Oncotarget|October 21, 2017
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screeningCheng-Lung Hsu, Jai-Shin Liu, Ting-Wei Lin, et al.Pageof 20